HCID 66914543, compound → HCID 66914516, compound
Reaction equation
Br[C:2]1[CH:11]=[CH:10][C:9]([C:12]2[C:13]([CH3:19])=[N:14][CH:15]=[C:16]([CH3:18])[CH:17]=2)=[C:8]2[C:3]=1[N:4]=[CH:5][CH:6]=[N:7]2.[C:20]([Cu])#[N:21]>CN1C(=O)CCC1.C(Cl)Cl.C(N)CN>[CH3:19][C:13]1[C:12]([C:9]2[C:8]3[N:7]=[CH:6][CH:5]=[N:4][C:3]=3[C:2]([C:20]#[N:21])=[CH:11][CH:10]=2)=[CH:17][C:16]([CH3:18])=[CH:15][N:14]=1Participants
6
Conditions
- Temperature
- 160 °C
Procedure
A mixture of 5-bromo-8-(2,5-dimethyl-pyridin-3-yl)-quinoxaline (Step 99.4) (189 mg, 0.60 mmol) and CuCN (70 mg, 0.78 mmol, 1.3 equiv) in NMP (2 mL) was stirred for 6 h at 160° C., under an argon atmosphere. The reaction mixture was allowed to cool to rt, diluted with DCM/10% aqueous solution of ethylenediamine (25 mL), extracted with DCM. The organic phase was washed with H2O and brine, dried (Na2SO4), filtered and concentrated. The residue was purified by silica gel column chromatography (DCM/MeOH/NH3aq, 94:5:1) to afford 150 mg of the title compound as a yellow solid. Title compound: ESI-MS: 261.2 [M+H]+; tR=1.92 min (System 1); TLC: Rf=0.68 (DCM/MeOH/NH3aq, 94:5:1).
Workup
- temperatureto cool to rt
- extractionextracted with DCM
- washThe organic phase was washed with H2O and brine
- dry with materialdried (Na2SO4)
- filtrationfiltered
- concentrationconcentrated
- customThe residue was purified by silica gel column chromatography (DCM/MeOH/NH3aq, 94:5:1)
Sources & evidence
- ORD record
- ord-dfa7ce6306ad40d9b3cf679150302c60
- Source dataset
- uspto-grants-2012_09
- Patent number
- US08273882B2
Reaction notes
Loading…